Sign up for free newsletter

 

Drugs

Monroe Capital provides USD27m for Collaborative Neuroscience Network ESOP transaction


Monroe Capital has provided a USD27m unitranche facility to support the sale of Collaborative Neuroscience Network (CNS Network) to a 100 per cent Employee Stock Ownership Plan (ESOP) owned corporation.

This is the first transaction completed by Monroe Capital’s newly-formed national ESOP lending practice.

ESOPs offer corporate and individual level tax advantages that are not typically available in traditional third party sales. In today’s rising tax rate environment, Monroe Capital anticipates that demand will be robust for similarly structured ESOP transactions in 2013 and beyond.

Based in Garden Grove, California, CNS Network is a clinical trial research provider, assisting pharmaceutical companies and contract research organisations with the various phases of drug development. The company provides services that manage various aspects of clinical trials for pharmaceutical companies testing potential compounds and drugs for FDA approval.


latestjobs
Hedge Fund Software Developer - C++/Java/Python

Tue, 09 Feb 2016 00:00:00 GMT

C/C++ Low Latency Developer – Core Technology

Tue, 09 Feb 2016 00:00:00 GMT

C++ Software Developer- Financial Start Up

Tue, 09 Feb 2016 00:00:00 GMT

events
1 week 57 min from now - Dubai
1 week 57 min from now - Cairo
1 week 1 day from now - New York
3 weeks 1 day from now - New York
specialreports
other gfm publications